Dual CD73/A2AR blockade modulates the neurotoxic astrocyte phenotype without disrupting core inflammatory signaling
Abstract
Introduction Excessive activation of the adenosine A 2A receptor (A 2A R) contributes to chronic neuroinflammation, in part through spatial coupling with the adenosine-generating enzyme CD73, which enables localized adenosine signaling. Coordinated regulation of Nt5e and Adora2a across neuropathological conditions supports dual targeting of the CD73/A 2A R axis to constrain maladaptive inflammatory signaling. Methods Primary rat astrocytes were exposed to TNF-α, IL-1α, and C1q (TIC) to induce a neurotoxic reactive astrocyte (nRA) substate. Concomitant pharmacological inhibition of CD73 (APCP, 100 μM) and A 2A R (istradefylline, 10 μM) was applied. Morphological, redox, inflammatory, and functional outcomes were assessed, including CD73 expression and activity, CD73/A 2A R spatial proximity, cytokine release, and astrocyte-mediated neurotoxicity. Results Dual CD73/A 2A R blockade attenuated key features of the nRA phenotype, including astrocyte hypertrophy, oxidative stress, and impaired antioxidant capacity. These effects were associated with normalization of CD73 expression and activity, reduced spatial proximity between CD73 and A 2A R, suppression of IL-1β release and complement- and immune cell-recruiting effector programs (C3, VCAM1), and modulation of redox-sensitive pathways ( Nos2 /NO, NRF2). Notably, IL-6- and TNFα-driven core inflammatory signaling remained preserved. Functionally, dual blockade shifted astrocytes toward a less neurotoxic phenotype, reducing their impact on neuronal Ca 2+ homeostasis and improving neuronal viability. Discussion These findings demonstrate that dual CD73/A 2A R blockade selectively reconfigures astrocyte inflammatory networks under the tested conditions, without broadly suppressing inflammatory or homeostatic functions at the examined time point. This supports the CD73/A 2A R axis as a promising therapeutic target for limiting chronic astrocyte-driven neurotoxicity.
Related
- Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation
- Disrupting the NAD+/NAM metabolic ratio driven by IL-1β inflammatory response potentiates chemotherapy and chemoimmunotherapy in mice
- Simvastatin Modulates Astrocyte and Microglial Reactivity and Aggressive Behavior After Chronic Sleep Deprivation in Rats.
- 1161 Novel IL1RAP expression gradient modulates the myeloid cell phenotype and T-cell infiltration patterns of the Ewing sarcoma immune microenvironment
- Pexidartinib modulates pro-inflammatory cytokines in a co-culture model of stromal-immune cell crosstalk in tenosynovial giant cell tumor
BibTeX
@article{mihajlovic2026dual,
title = {{Dual CD73/A2AR blockade modulates the neurotoxic astrocyte phenotype without disrupting core inflammatory signaling}},
author = {Katarina Mihajlovic and Milorad Dragic and Marija Adzic Bukvic and Teodora Martic and Ivana Stevanovic and Stéphane Vinit and Marêva Bleuzé and Arnaud Mansart and Lucille Adam and Nadezda Nedeljkovic},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1778355},
url = {https://hal.science/hal-05851882v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dual CD73/A2AR blockade modulates the neurotoxic astrocyte phenotype without disrupting core inflammatory signaling
AU - Katarina Mihajlovic
AU - Milorad Dragic
AU - Marija Adzic Bukvic
AU - Teodora Martic
AU - Ivana Stevanovic
AU - Stéphane Vinit
AU - Marêva Bleuzé
AU - Arnaud Mansart
AU - Lucille Adam
AU - Nadezda Nedeljkovic
PY - 2026
DA - 2026/11/04
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1778355
UR - https://hal.science/hal-05851882v1
AB - Introduction Excessive activation of the adenosine A 2A receptor (A 2A R) contributes to chronic neuroinflammation, in part through spatial coupling with the adenosine-generating enzyme CD73, which enables localized adenosine signaling. Coordinated regulation of Nt5e and Adora2a across neuropathological conditions supports dual targeting of the CD73/A 2A R axis to constrain maladaptive inflammatory signaling. Methods Primary rat astrocytes were exposed to TNF-α, IL-1α, and C1q (TIC) to induce a neurotoxic reactive astrocyte (nRA) substate. Concomitant pharmacological inhibition of CD73 (APCP, 100 μM) and A 2A R (istradefylline, 10 μM) was applied. Morphological, redox, inflammatory, and functional outcomes were assessed, including CD73 expression and activity, CD73/A 2A R spatial proximity, cytokine release, and astrocyte-mediated neurotoxicity. Results Dual CD73/A 2A R blockade attenuated key features of the nRA phenotype, including astrocyte hypertrophy, oxidative stress, and impaired antioxidant capacity. These effects were associated with normalization of CD73 expression and activity, reduced spatial proximity between CD73 and A 2A R, suppression of IL-1β release and complement- and immune cell-recruiting effector programs (C3, VCAM1), and modulation of redox-sensitive pathways ( Nos2 /NO, NRF2). Notably, IL-6- and TNFα-driven core inflammatory signaling remained preserved. Functionally, dual blockade shifted astrocytes toward a less neurotoxic phenotype, reducing their impact on neuronal Ca 2+ homeostasis and improving neuronal viability. Discussion These findings demonstrate that dual CD73/A 2A R blockade selectively reconfigures astrocyte inflammatory networks under the tested conditions, without broadly suppressing inflammatory or homeostatic functions at the examined time point. This supports the CD73/A 2A R axis as a promising therapeutic target for limiting chronic astrocyte-driven neurotoxicity.
SN - 1663-9812
ER -